Skip to main content
SpringerLink
Log in

ESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes

Was ist neu?

ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death

What is new?

  • Schwerpunkt
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Die auf der diesjährigen Jahrestagung der European Society of Cardiology (ESC) in London vorgestellten Leitlinien zur Therapie von Patienten mit ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes umfassen eine umfangreiche Aktualisierung der Empfehlungen zur Diagnostik sowie zur medikamentösen, interventionellen und Device-gestützten Therapie ventrikulärer Tachyarrhythmien. Die bereits vorhandenen Leitlinien zur primär- und sekundärprophylaktischen ICD (implantierbarer Kardioverter-Defibrillator)-Implantation wurden punktuell erweitert. Die Empfehlungen zur Katheterablation ventrikulärer Tachykardien wurden aktualisiert und, der zunehmenden Datenlage Rechnung tragend, ausgeweitet. Hinsichtlich Diagnostik und Therapie hereditärer Arrhythmien erfolgte größtenteils eine Angleichung an den 2013 publizierten Konsensusreport der Expertenkommission der American Heart Association (AHA), der European Heart Rhythm Association (EHRA) und der Asia Pacific Heart Rhythm Society (APHRS).

Abstract

The new European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmia and the prevention of sudden cardiac death, recently published at the annual ESC meeting in London, contain an extensive update of the recommendations for the diagnostics, drug therapy, interventional and device therapy of ventricular arrhythmia. The new recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prophylaxis of sudden cardiac death can be seen as a focused update of the previously published guidelines. Pre-existing recommendations for catheter ablation of ventricular arrhythmias have been partly extensively expanded with respect to the results of recent clinical trials. The guideline committee also adapted their recommendations regarding the hereditary arrhythmia syndromes to the 2013 consensus report of the American Heart Association (AHA), the European Heart Rhythm Association (EHRA) and the Asia Pacific Heart Rhythm Society (APHRS).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Priori SG et al (2015) ESC 2015 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace [Epub ahead of print]

  2. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com. J Am Coll Cardiol 48(5):e247–e346

    Article  PubMed  Google Scholar 

  3. Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T et al (2014) EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace 16(9):1257–1283

    Article  PubMed  Google Scholar 

  4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1–e62

    Article  PubMed  Google Scholar 

  5. Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NAM et al (2012) ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61(3):e6–e75.

    Article  PubMed  Google Scholar 

  6. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 34(29):2281–2329

    Article  PubMed  Google Scholar 

  7. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10(12):1932–1963

    Article  PubMed  Google Scholar 

  8. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al (2013) ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128(16):e240–e327

    Article  PubMed  Google Scholar 

  9. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR et al (2014) HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation 130:94–125

    Article  PubMed  Google Scholar 

  10. Basso C, Burke M, Fornes P, Gallagher PJ, De Gouveia RH, Sheppard M et al (2008) Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 452(1):11–18

    Article  PubMed  Google Scholar 

  11. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al (1997) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940

    Article  Google Scholar 

  12. Bigger TJ (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337:1569–1575

    Article  PubMed  Google Scholar 

  13. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890

    Article  CAS  PubMed  Google Scholar 

  14. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883

    Article  PubMed  Google Scholar 

  15. Bardy GH, Lee KL, Mark DB, Poole JE, Packer D, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237

    Article  CAS  PubMed  Google Scholar 

  16. Desai A, Fang JC, Maisel WH, Baughman KL (2004) Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292(23):2874–2879

    Article  CAS  PubMed  Google Scholar 

  17. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K et al (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105(12):1453–1458

    Article  PubMed  Google Scholar 

  18. Krueger S, Kass DA, Marco T De, Carson P, Dicarlo L, Demets D et al (2009) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150

    Google Scholar 

  19. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158

    Article  CAS  PubMed  Google Scholar 

  20. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J Am Coll Cardiol 41(10):1707–1712

    Article  PubMed  Google Scholar 

  21. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21(24):2071–2078

    Article  CAS  PubMed  Google Scholar 

  22. Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO et al (1999) Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. Circulation 99(13):1692–1699

    Article  CAS  PubMed  Google Scholar 

  23. Kuck KH, Cappato R, Siebels J, Rüppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102(7):748–754

    Article  CAS  PubMed  Google Scholar 

  24. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101(11):1297–1302

    Article  CAS  PubMed  Google Scholar 

  25. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M et al (2013) Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 128(9):944–953

    Article  PubMed  Google Scholar 

  26. Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M et al (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythmia Electrophysiol 5(5):913–919

    Article  Google Scholar 

  27. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L et al (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363(1):36–44

    Article  CAS  PubMed  Google Scholar 

  28. Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA et al (2015) Safety and efficacy of the totally subcutaneous implantable defibrillator. J Am Coll Cardiol 65(16):1605–1615

    Article  PubMed  Google Scholar 

  29. Jarman JWE, Lascelles K, Wong T, Markides V, Clague JR, Till J (2012) Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 33(11):1351–1359

    Article  PubMed  Google Scholar 

  30. Jarman JWE, Todd DM (2013) United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 15(8):1158–1165

    Article  PubMed  Google Scholar 

  31. Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S et al (2013) Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Hear Rhythm 10(1):29–36

    Article  Google Scholar 

  32. Lambiase PD, Barr C, Theuns DAMJ, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry. Eur Heart J 35(25):1657–1665

    Article  PubMed Central  PubMed  Google Scholar 

  33. Olde Nordkamp LRA, Knops RE, Bardy GH, Blaauw Y, Boersma LVA, Bos JS et al (2012) Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J 163(5):753–760.e2

    Article  PubMed  Google Scholar 

  34. Auricchio A, Klein H, Geller CJ, Reek S, Heilman MS, Szymkiewicz SJ (1998) Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation. Am J Cardiol 81(10):1253–1256

    Article  CAS  PubMed  Google Scholar 

  35. Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD et al (2010) Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 56(3):194–203

    Article  PubMed Central  PubMed  Google Scholar 

  36. Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV et al (2013) Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol 62(21):2000–2007

    Article  PubMed  Google Scholar 

  37. Kao AC, Krause SW, Handa R, Karia D, Reyes G, Bianco NR et al (2012) Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord 12(1):123

    Article  PubMed Central  PubMed  Google Scholar 

  38. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357(26):2657–2665

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM et al (2000) Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter. J Am Coll Cardiol 35(7):1905–1914

    Article  CAS  PubMed  Google Scholar 

  40. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T et al (2008) Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118(25):2773–2782

    Article  PubMed  Google Scholar 

  41. Tanner H, Hindricks G, Volkmer M, Furniss S, Kühlkamp V, Lacroix D et al (2010) Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol 21(1):47–53

    Article  PubMed  Google Scholar 

  42. Kuck K-H, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31–40

    Article  PubMed  Google Scholar 

  43. Waldo AL (2007) Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. Yearb Cardiol 2007(2):450–451

    Article  Google Scholar 

  44. Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C et al (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129(7):728–736

    Article  PubMed  Google Scholar 

  45. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G et al (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 117(4):462–469

    Article  PubMed  Google Scholar 

  46. Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C et al (2010) Relationship between burden of premature ventricular complexes and left ventricular function. Hear Rhythm 7(7):865–869

    Article  Google Scholar 

  47. Deyell MW, Park KM, Han Y, Frankel DS, Dixit S, Cooper JM et al (2012) Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations. Hear Rhythm 9(9):1465–1472

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland

    T. Fink,  K.H. Kuck &  A. Metzner

Authors
  1. T. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K.H. Kuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Metzner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Metzner.

Ethics declarations

Interessenkonflikt

T. Fink, K.H. Kuck und A. Metzner geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fink, T., Kuck, K. & Metzner, A. ESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes. Herz 40, 1034–1042 (2015). https://doi.org/10.1007/s00059-015-4380-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-015-4380-6

Schlüsselwörter

Keywords

Search

Navigation